Natalia Badillo
Direttore Finanziario/CFO presso Friede & Goldman Ltd.
Profilo
Natalia Badillo is currently the Chief Financial Officer at Friede & Goldman Ltd.
since 2008.
Prior to this, she worked as a Finance Director at Janssen-Cilag International NV.
She holds an MBA from INSEAD.
Posizioni attive di Natalia Badillo
| Società | Posizione | Inizio |
|---|---|---|
Friede & Goldman Ltd.
 Friede & Goldman Ltd. Contract DrillingIndustrial Services Friede & Goldman Ltd. designs and manufactures mobile offshore drilling and production units. It offers naval architects and marine engineering services. The company was founded by Vladimir M. Friede and Jerome L. Goldman and is headquartered in Houston, TX. | Direttore Finanziario/CFO | 04/08/2009 |
Precedenti posizioni note di Natalia Badillo
| Società | Posizione | Fine |
|---|---|---|
Janssen-Cilag International NV
 Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Direttore Finanziario/CFO | - |
Formazione di Natalia Badillo
| INSEAD | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Friede & Goldman Ltd.
Friede & Goldman Ltd. Contract DrillingIndustrial Services Friede & Goldman Ltd. designs and manufactures mobile offshore drilling and production units. It offers naval architects and marine engineering services. The company was founded by Vladimir M. Friede and Jerome L. Goldman and is headquartered in Houston, TX. | Industrial Services |
Janssen-Cilag International NV
Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Health Technology |
- Borsa valori
- Insiders
- Natalia Badillo
